Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03728751 · ClinicalTrials.gov registry record · NA
Optimal Time for In-situ Dry Needling to Affect the Autonomic Nervous System
A NA study of Healthy, sponsored by Florida Gulf Coast University.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT03728751 is a NA study of Healthy that has completed, run by Florida Gulf Coast University. The registered enrollment target is 20 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03728751, a NA study of Healthy, has completed, sponsored by Florida Gulf Coast University.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
Assessing for optimal time dry needles need to remain inside the body to have positive effect on the nervous system
Conditions Studied
Interventions
- PROCEDURE Dry needling
Study Locations (1)
Indiana
- Integrated Therapy Practice PC - Hobart
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2018-09-01 |
| Est. Completion | 2018-10-29 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03728751
The ClinicalTrials.gov registry entry for NCT03728751 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (97% lower). The listed sponsor is Florida Gulf Coast University, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 1 intervention - of which Dry needling is the first listed.
NCT03728751 reports 1 study location spanning 1 distinct geographic area - top geographies include Indiana.
Frequently Asked Questions
What is clinical trial NCT03728751 about?
NCT03728751 is a clinical study titled "Optimal Time for In-situ Dry Needling to Affect the Autonomic Nervous System". Assessing for optimal time dry needles need to remain inside the body to have positive effect on the nervous system
What is the current status of trial NCT03728751?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2018-09-01. Estimated completion is 2018-10-29.
What conditions does trial NCT03728751 study?
This clinical trial studies the following conditions: Healthy.
What interventions are being tested in trial NCT03728751?
The interventions under investigation include: Dry needling (PROCEDURE).
Who is sponsoring clinical trial NCT03728751?
This trial is sponsored by Florida Gulf Coast University, which has 11 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03728751 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Neuromodulation-assisted Ego-disengagement: The NEURO-EGO Study Stage 1
RECRUITING · NA
-
Oxalate and Citrate in Humans - Response to Citrate
RECRUITING · NA
-
CArdioMEtabolic Function and Reserve Capacity in Healthy Adults: The CAMERA Study
RECRUITING · NA
-
Examining Bronchial Hyperresponsiveness in Primary Ciliary Dyskinesia
RECRUITING · NA
-
Medical Illustration Design Characteristic Evaluation
RECRUITING · NA
-
Sodium vs Potassium Education to Improve Vascular Health
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.